Abstract: In one example, an electronic device includes a substrate including a substrate upper side and a conductive structure comprising substrate upper terminals adjacent to the substrate upper side. Vertical interconnects are coupled to the substrate upper terminals. An encapsulant covers portions of the substrate and the vertical interconnects. The vertical interconnects are exposed from an upper side of the encapsulant. A redistribution structure is over the encapsulant and includes a redistribution structure upper side, a redistribution structure lower side, a redistribution dielectric structure, and a redistribution conductive structure. The redistribution structure includes redistribution upper terminals adjacent to the redistribution structure upper side and redistribution bottom terminals adjacent to the redistribution lower side. The redistribution bottom terminals are coupled to the vertical interconnects and the redistribution upper terminals.

Abstract: A display device includes a display unit having pixels, a touch sensing unit including touch electrodes disposed on the display unit, and a touch driver configured to supply a touch driving signal to the plurality of touch electrodes and receive a touch sensing signal from the touch electrodes. The touch driver supplies a first touch driving signal having a first phase to one or more first touch electrodes, and supplies a second touch driving signal having a second phase opposite to the first phase to one or more second touch electrodes, at least a part of which is disposed across a specific point from the first touch electrodes. The touch driver receives a first touch sensing signal having the first phase from at least one of the first touch electrodes, and receives a second touch sensing signal having the second phase from at least one of the second touch electrodes.

Abstract: Disclosed is an anodeless all-solid-state battery including a porous composite membrane in place of an anode current collector.

Abstract: A unit pixel includes a transparent substrate, a plurality of light emitting devices arranged on the transparent substrate, connection layers electrically connected to the light emitting devices, and bonding pads disposed over the connection layers and electrically connected to the connection layers. The bonding pads are partially overlapped with at least one of the light emitting devices in a vertical direction, respectively.

Abstract: Provided are novel fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and uses thereof.

Abstract: Provided are novel carbonohydrazonoyl dicyanide compounds including two or more aryl or heteroaryl groups connected via a linker and uses thereof.

Abstract: Provided are novel oxopyridazinyl-phenyl-carbonohydrazonoyl dicyanide compounds and uses thereof.

Abstract: Provided is a composition for injection containing isolated mitochondria. More specifically, provided is a liquid composition for injection containing glycine, saccharide, buffer, and mitochondria, and a pharmaceutical composition comprising the liquid composition for injection as an active ingredient. The liquid composition for injection according to the present disclosure is capable of securing the safety of a mitochondrial therapeutic and maintaining the activity of mitochondria, by enhancing the stability of mitochondria for prevention or treatment of mitochondria-related diseases and preventing and inhibiting formation of blood clots in the blood of a subject who is administered with the same.

Abstract: The present invention relates to novel hydrazone derivatives in which a terminal amine group is substituted with an aryl group or a heteroaryl group, and uses thereof.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating myositis. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating myositis, comprising mitochondria as an active ingredient. When the pharmaceutical composition of the present invention comprising exogenous mitochondria as an active ingredient is administered to a subject suffering from myositis, inflammatory cells infiltrated into the muscle cells of the subject can be reduced. In addition, the pharmaceutical composition of the present invention effectively inhibits the expression of IL-1?, TNF-?, and IL-6, inflammatory cytokines. Therefore, the pharmaceutical composition according to the present invention can be usefully used for preventing or treating myositis.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of sepsis or systemic inflammatory response syndrome (SIRS) comprising mitochondria as effective ingredient. When activated macrophages and monocytes are treated with mitochondria which are effective ingredient of the pharmaceutical composition of the present invention, expression of IL-1?, TNF-? and IL-6 which are pro-inflammatory cytokines can be restored to normal levels. Furthermore, when the pharmaceutical composition of the present invention is administered to a subject suffering from sepsis, the survival rate of the subject can be remarkably increased. Therefore, the pharmaceutical composition according to the present invention can be useful for the treatment of sepsis.

Abstract: A wireless power relaying device and a display system that distributes power wirelessly. A wireless power relaying device includes a relay coil producing a second magnetic field by a current induced from a first magnetic field produced from a first external device, and a magnetic body on which the relay coil is arranged. The magnetic body includes first, second, and third magnetic bodies arranged at a same distance from each other. A direction in which the relay coil is wound around the first magnetic body is different from a direction in which the relay coil is wound around the second and third magnetic bodies. The direction in which the relay coil is wound around the second coil is the same as the direction in which the relay coil is wound around the third coil. A power signal is sent to a second external device through the second magnetic field.

Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of stroke.

Abstract: A display device includes: a display panel including a plurality of pixels; a data driver configured to supply a black voltage to the display panel; and a controller configured to: set an initial driving power voltage of the display panel; decide a bright spot voltage of the display panel while the data driver is supplying the black voltage to the display panel; and set any one of the bright spot voltage and the initial driving power voltage as a final driving power voltage.

Abstract: Provided is a wireless power transceiver including a magnetic body, a solenoid coil wound with respect to the magnetic body, and a dual coil spaced downwardly from the solenoid coil and wound with respect to the magnetic body on opposite sides of the solenoid coil, the dual coil being wound in directions opposite to each other.

Abstract: The present invention relates to a novel halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative or a pharmaceutically acceptable salt thereof; a preparation method thereof; and an Nrf2 activator and a pharmaceutical composition for preventing or treating diseases induced by a decrease in Nrf2 activity, both of which comprise the same as an active ingredient.

Abstract: The present invention relates to an electronic apparatus and display apparatus, and method for driving the apparatuses, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a rectification unit for rectifying the output voltage of the resonance circuit unit; and a converter for outputting the rectified voltage of the rectification unit as the target voltage by varying duty on the basis of duty data and target voltage determined in accordance with the distance from the external apparatus.

Abstract: The present invention relates to a display apparatus and operational method therefor, and an electronic apparatus, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a capacitance variance unit for varying the capacitance (Cv) of the resonance circuit unit in order to control the resonance point thereof, the resonance point having been changed due to the distance from the external apparatus; and a display panel for implementing an image by means of the voltage.

Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of spinal cord injury.

Abstract: Provided are bifunctional small molecules of Formula (I): or pharmaceutically acceptable salts thereof, wherein M represents a small organic molecule which binds, covalently or non-covalently, a kinase, such as Her3 protein kinase; L1 represents a linker; and RH represents a hydrophobic group. An example of a compound of Formula (I) is a compound of Formula (II): Also provided are pharmaceutical compositions comprising a compound of Formula (I) or (II) and methods of using such compounds for treating proliferative diseases.